Clinical trial Recruiting at 1 site Interventional Ages 10 to 19

Horse Riding Simulator Added to Core Exercises in Adolescents with Idiopathic Scoliosis

Official title: Effectiveness of a Horse Riding Simulator in Adolescents With Idiopathic Scoliosis

Run by Bezmialem Vakif University · NCT07758712 · Data updated 2026-11-12

In adolescents with idiopathic scoliosis, adding a horse riding simulator to a core stabilization program is being tested to see if it improves breathing muscle strength, balance, quality of life, and how they feel about their posture.

More Postural Balance trials

Quick facts

Study typeInterventional
Ages10 Years to 19 Years
SexAll
Enrollment30 (estimated)
SponsorBezmialem Vakif University
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedAugust 5, 2026
Main results expectedJanuary 10, 2027
Study endsJanuary 10, 2027
Registry record updatedOctober 22, 2026
Trial IDNCT07758712 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adolescents aged 10–19 with idiopathic scoliosis and a Cobb angle between 10° and 40°, eligible to participate and without recent spine surgery or other conditions that prevent exercise.

Probably not a fit

Patients with non-idiopathic scoliosis, recent spine surgery, or medical conditions precluding exercise may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial tests whether combining a horse riding simulator with core stabilization exercises provides added benefits for adolescents with AIS. The study focuses on respiratory muscle strength, balance, health-related quality of life, and perceived cosmetic deformity. Participants are aged 10–19 with a Cobb angle of 10°–40°, and are randomized to receive either the combination therapy or core stabilization alone. The intervention uses a horse riding simulator to mimic multidirectional pelvic and trunk movements to enhance postural control. Results will inform conservative management strategies for AIS and the role of simulated equine therapy in this population.

Why it matters

Potential benefit: If successful, the approach could improve trunk strength, balance, and overall quality of life for adolescents with AIS.

How similar studies have gone: Prior conservative therapies for AIS have shown benefits with core stabilization; the added horse riding simulator is a novel component with limited prior clinical evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of adolescent idiopathic scoliosis
* Age between 10 and 19 years
* Cobb angle between 10° and 40°, measured on standing spinal radiographs
* Willingness of the participant and, when applicable, the parent or legal guardian to participate in the study

Exclusion Criteria:

* Scoliosis of a non-idiopathic etiology
* History of surgery within the previous 3 months
* Presence of an orthopedic, neurological, or systemic condition that may prevent participation in the exercise program
* Cognitive, communication, or behavioral disorders that may interfere with understanding instructions, answering questions, or performing the exercises
* Participation in regular exercise on 3 or more days per week

Where it's running

  • Bezmialem Vakıf University
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.